Classification of drug-related problems;Klassifisering av legemiddelrelaterte problemer

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 23, 2007, Pages 3073-3076

  Ruths, Sabine ^a,b   Viktil, Kirsten K ^c   Blix, Hege Salvesen ^d  

^a RAG Mining Solutions GmbH   (Germany)

^b Unifob Helse   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d LOVISENBERG DIAKONALE HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CLASSIFICATION; CONSENSUS; DRUG INTERACTION; DRUG SURVEILLANCE PROGRAM; DRUG THERAPY; HUMAN; MEDICATION ERROR; NORWAY; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; RISK FACTOR; STANDARD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CONSENSUS; DRUG INTERACTIONS; DRUG THERAPY; GUIDELINE ADHERENCE; HUMANS; MEDICATION ERRORS; NORWAY; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; PRESCRIPTIONS, DRUG; RISK FACTORS;

EID: 38349126000     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mannesse CK, Derkx FH, de Ridder MA et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35-9.
2. Ebbesen J, Buajordet I, Erikssen J et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001; 161: 2317-23.
3. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192-9.
4. Furniss L, Burns A, Craig SK et al. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry 2000; 176: 563-7.
5. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003; 12: 176-80.
6. Blix HS, Viktil KK, Reikvam A et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004; 60: 651-8.
7. Mannheimer B, Ulfvarson J, Eklof S et al. Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 2006; 62: 1075-81.
8. Granas AG, Bates I. The effect of pharmaceutical review of repeat prescribing in general practice. Int J Pharm Pract 1999; 7: 264-75.
9. Zermansky AG, Petty DR, Raynor DK et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1340.
10. St.meld. nr. 18 (2004-2005). Rett kurs mot riktigere legemiddelbruk. Legemiddelpolitikken.
11. Viktil KK, Blix HS, Moger TA et al. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 2006; 15: 667-74.
12. Kaboli PJ, Hoth AB, McClimon BJ et al. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166: 955-64.
13. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
14. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999; 21: 245-50.
15. Pharmaceutical Care Network Europe. PCNE Classification for drug-related problems V5.01. www.pcne.org/dokumenter/PCNE %20classificationV501.pdf (22.1.2007).
16. Pharmacy Guild of Australia. PROMISe Phase One Final report. Hobart: University of Tasmania, 2003. (http://beta.guild.org.au/uploadedfiles/ Research_and_Development_Grants_Program/Projects/2003-504_fr.pdf (22.1.2007).)
17. Jones J, Hunter D. Qualitative research: consensus methods for medical and health services research. BMJ 1995; 311: 376-80.
18. Van Mil JW, Westerlund LOT, Hersberger KE et al. Drug-related problem classification systems. Ann Pharmacother 2004; 38: 859-67.